<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome is characterized by venous and/or <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo>, repeated <z:e sem="disease" ids="C0000786" disease_type="Disease or Syndrome" abbrv="">miscarriages</z:e> and the presence of anticardiolipin antibodies and/or a circulating <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Antibodies directed against <z:chebi fb="1" ids="16247">phospholipids</z:chebi> constitute a family of immunoglobulins with different specificities </plain></SENT>
<SENT sid="2" pm="."><plain>The mechanism through which lesions are induced by these antibodies has not yet been fully determined </plain></SENT>
<SENT sid="3" pm="."><plain>Treatment includes immunosuppressive measures and prevention of <z:hpo ids='HP_0004419'>recurrent thrombosis</z:hpo> </plain></SENT>
</text></document>